205 Great Valley Parkway
Malvern,  PA  19355

United States
  • Booth: 501

Fujirebio is a world leader in the production of in vitro diagnostics with a focus in oncology and infectious disease biomarkers. With over 30 years of experience and supplying the IVD industry with oncology markers, Fujirebio is expanding its offering to include automated immunoassay systems. With over 20 years of history in the Japanese Clinical laboratory market, the newest fully automated system, the LUMIPULSE® G1200, is now FDA cleared for sale in the United States.


  • LUMIPULSE® G1200
    Fujirebio presents the LUMIPULSE G1200. A robust mid-sized fully automated immunoassay instrument. The LUMIPULSE G1200 is based on CLEIA (chemiluminescent enzyme immunoassay) technology. The unique and user friendly system offers multiple features to simplify your workload. ...

  • Fujirebio presents the LUMIPULSE G1200, a robust mid-sized fully automated immunoassay instrument. 

    The LUMIPULSE G1200 is based on CLEIA (chemiluminescent enzyme immunoassay) technology.

    This unique and user-friendly system offers the following features to simplify your workflow:

    • Continuous access loading and unloading of samples, reagents and consumables without operational interruption
    • > 300 days mean time between failure
    • Disposable tips to eliminate contamination and sample carry over
    • A unitized test cartridge to reduce waste of reagent and eliminate cross contamination
    • 120 tests / hour
    • Stand alone or capable of connecting to track systems

    Assays now available in the United States: 25-OH Vitamin D, CA125II, HE4, and ROMA®.



    • AACC Annual Scientific Meeting & Clinical Lab Expo Management
    • SPARGO, Inc.
    • Toll Free (800) 564-4220
    • Phone:  (703) 631-6200
    • Fax (703) 563-2691
    • Email:  aaccexhibits@spargoinc.com